Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

iRhythm Settles Patent Case After 'Settled Expectations' Ruling

8 August 2026 · By · Wire by Fusion42

Published

8 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at news.bloomberglaw.com →

◆ Verified

Fusion42 · 28 August 2026 · Fusion42 review

iRhythm has settled a patent infringement case following a key ruling on 'settled expectations' that impacts how patent damages might be calculated in future cases.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Patent disputes in medical technology now involve tighter damage assessments, making it more critical for you to evaluate patent risk and potential settlements early in your product cycle.

◆ Coverage

1 source · 8 Aug 2026

◆ Related on Wire

◆ Topics

Medtechpatentmedtechlitigationip-lawsettlement